Brakke Viewpoints
We are the experts in animal healthThoughts on Third Quarter Earnings
The main shift in growth performance can be attributed to innovation. Both Elanco and Merck have invested in developing new product entrants targeting market segments that Zoetis has dominated, launching competitive products in the combination and long-acting parasiticide, and dermatology segments.
Another aspect of bolstering performance is product line balance. Elanco has the most balanced product line with a 51% companion animal (CA) /48% livestock (L) split into segments. Merck’s split is 40/60 and Zoetis is 67/32. Most industries, including animal health, run in cycles. Diversification is important to weather the ups and downs of the various market segments.
In the end, it looks like the industry will deliver overall growth rates in line with historical averages. To learn more about industry performance and trends, please join the Brakke team for the Annual Industry Overview presentation at both VMX in Orlando and WVC in Las Vegas in early 2027.
Senior Consultant
Brakke Viewpoint November 13, 2026
All through 2026 one word that we’ve been hearing repeatedly is “headwinds.” Corporate quarterly reports, especially those with weak performance or revenues that were less than what was anticipated, are quick to blame headwinds. Veterinary visits are down. Vets are seeing fewer dogs, which make up the vast majority or practice revenue, even if they are seeing more cats. Consumer budgets are tight.
And yet . . . many companies are doing just fine, thank you. Two company releases in this newsletter report revenues well above industry average. In last week’s newsletter there were several more. There are many reasons. Some are well diversified in both companion animal and food animal sectors; the food animal sector has been very strong this year. Others are benefiting from innovation. Still others participate in segments – or have created segments (for example- fresh pet food) – that are rapidly catching on with consumers. Still others are simply doing a better-than-average job of managing their resources and capturing share. It’s easy to blame external factors when things aren’t going as well as we had hoped. It’s much harder to create novel strategies and make those bold decisions that drive success even when the market is down. We hope you’re the latter one.
John Volk
Senior Consultant
Brakke attends AHNTI
Last week two Brakke colleagues and I attended Animal Health, Nutrition &Technology Innovation (AHNTI) in Boston and gained a firsthand look at how innovation is thriving in our industry. At this meeting we saw top companies talking to the startups and innovators but, there were also many other potential partners including patent attorneys, formulators, contract research companies, consultants, veterinary hospital groups, etc.
We had many productive meetings with several innovators, and once again were impressed by the quality of their ideas and their energy and resilience as they worked to make the ideas become reality. From extending the life of our pets, better medicines and biologicals for unmet needs, technology to improve efficiency at veterinary hospitals, to a robot that creates running herds of turkeys which make them grow faster with more muscle, the creativity was impressive. Clearly, rapid advanced in technology, including AI, are helping accelerate innovation.
Brakke was there to help move innovation forward. We support innovators and companies seeking innovation in three key areas:
- Market assessment and strategy: Evaluate market opportunities and develop strategies and go-to-market plans.
- Connections and partnerships: Connect innovators with the best providers, experts, opinion leaders, and partners.
- Recruiting: Address recruiting needs.
I am eager to see how the innovation we saw at this meeting develop towards generating growth in our Animal Health Industry and better lives for animals and people that care for them.
Cristiano von Simson
Senior Consultant
Price transparency: what you see is what you pay
Late last month, I spent some time vacationing in Germany and France. Like the US, Europe is facing inflation and higher costs- I was prepared that this trip might cost us a bit, but I was pleasantly surprised by what we experienced. The one area that surprised me the most was dining. I found that for dining the price transparency surrounding our meals was greatly appreciated. The cost of the meal ALWAYS came to the price on the menu – tipping was completely optional and could only be done if left in euros or if I advised the server what the total should be when using a credit card. When charging to a card there never as an “additional” processing fee for that convenience and there was never a “suggested” tip amount for me to consider. Here in the US – it’s hard to find that type of price transparency in most places. But there are some veterinary practices (both corporate and independent) that are trying to do this. For some it’s a way to encourage participation in membership plans by highlighting the “savings” that members receive and for others it may be a way to differentiate their services from competitors. In an economy with inflation and concerns about cost- transparency is more appreciated than ever.
Dr. Christine Merle, Editor
Reflecting on Risk
Reflecting on Risk
Understanding and coping with risk starts early in our lives from the first time we ride a bicycle without training wheels, to building up the nerve to ask that girl out. The multitude of early life experiences frames how we process and deal with risk when we enter the business world.
When it comes to risk management in business, it is interesting to see how it plays out in the day-to-day operations. ‘Risk is the seed of change’ Can you imagine the ‘hand ringing’ in Zoetis years ago investing in a new technology called ‘biological therapeutic agents’, an unknown in veterinary medicine at that time? Now we have multi-billion-dollar markets as a result! What a risky move, one might say…
In companies that have a high-risk tolerance, chances are if the business case is sound, and the risks are identified clearly and well thought out, risk is rewarded by backing the play. These companies have some catastrophic failures but also game-changing successes.
In low-risk tolerant companies, you go through multiple reviews and presentations, and the audience stares at each other until a ‘consensus’ is formed. Or they wait till the CEO gives a thumbs up or thumbs down. And some of those companies may eventually disappear.
In my view, those companies that embrace a high-risk tolerance with a robust discipline around the management of risk are the ones that are the most successful and the most sustainable. How is it in your company?
Paul Casady Senior Consultant
Eye-Watering Fuel Prices
It’s early Thursday, and I’m on the road to California for an event. This marks my first drive in my diesel Sprinter van since the beginning of summer. With the route planned and everything packed, I started looking at fuel prices to map out my stops.
That’s when the sticker shock hit.
Diesel is currently $5.96 per gallon locally. Curious about prices farther along my route, I checked the next state and found it hovering around $6.85 per gallon. Then I looked at California. Since I’ll be there for roughly ten days, a fill-up is inevitable. The price? An eye-watering $8.41 per gallon.
As painful as those numbers are, they’re not enough to keep me from making the trip. I may be a little more strategic about where I fuel up, but my plans remain unchanged. The truth is that rising fuel costs touch everyone. Whether fuel is a business expense or part of a hobby, increased energy costs eventually show up in the price of nearly everything we buy through higher production and transportation costs.
Chuck Johnson DVM, MBA
Senior Consultant
Think Crowdfunding Stinks? Maybe Not for Animal Health.
Think Crowdfunding Stinks? Maybe Not for Animal Health.
Think crowdfunding stinks and is mostly for companies that could not raise money from “real” investors?
A lot of VCs and institutional investors seem to think so. And, frankly, crowdfunding has done plenty to earn that poor reputation. Over the past decade, too many companies raised money and then communicated poorly, failed to provide meaningful follow-up, or simply failed. Broad crowdfunding platforms have not helped. Put a pizza franchise, a consumer gadget and a potential cancer therapy next to each other, and it is hard to argue that investors are looking at a carefully curated investment marketplace.
But I increasingly believe we may be dismissing a useful financing tool because of how it has been used. Animal health is different.
Many innovative companies in our industry need $500,000 to $5 million to reach the next meaningful clinical, regulatory or commercial milestone. That can be too much for founders and traditional angels, but too small to attract efficient attention from many venture funds. Reg CF (the regulation that defines the rules for the crowdfunding space) happens to operate right in that gap.
And animal health has something else: millions of veterinarians, industry professionals and pet owners who already care deeply about the problems these companies are trying to solve.
The model I find compelling is not “crowd first.” It is good science → expert diligence → specialist investors → broader, educated participation. Some recent success stories in our space show that sophisticated capital and community capital can coexist.
Crowdfunding will not replace professional investors, nor should it. But for an industry that has complained for years about the shortage of early-stage capital, perhaps it deserves another look.
Great Resignation, Great Stay. Now Great Pause. What in the world?
Brakke Consulting Viewpoint
Great Resignation, Great Stay. Now Great Pause. What in the world?
Candidates are stepping away from the job market altogether. Zogby’s recent survey of over 1500 US adults for Employ* confirms media reports that not only is it taking longer for candidates to secure a job, but it’s also getting harder. 2025’s results show that 41% indicated securing a job would take 1-3 months, with 30% responding 4-6 months. We’ve slipped. This year, the 1-3-month percentage dropped to 37%, while the 4-6-month tally was 33%. Those estimating 7-9 months rose from 7% to 9%.
It gets gloomier. In 2025, 44% said getting a job was “Somewhat” or “Very” easy,” with 55% indicating “Somewhat” to “Very” difficult. This year’s tallies: 35%, and 64%, respectively.
So now what? Employ suggests employers take actions to stem that discouraging tide:
- Be specific about stability, growth, and team culture
- Reduce uncertainty; clarify timelines and expectations
- Move faster, share conclusive decisions and actions
- Target well-qualified candidates vs a shotgun approach
- Look inward; cultivate your team
Amazing how quickly things changed from candidate-friendly to candidate-unfriendly. Plenty of fine candidates seek new roles. A clear, streamlined approach stands out. Brakke can help.
Jeff Santosuosso
Senior Consultant
* 2026 Job Seeker Nation Report, Employ
Lessons from Dolly
I couldn’t help but read the many tributes to Dolly Parton this week. I do not have any stories to tell about her other than she owned a small cottage in Solvang, California, which is in the Santa Ynez Valley where I grew up and where most of my family still lives. But the story of her life is amazing and something that we can learn from.
We learned from these tributes how kind, considerate and generous she was to everyone, not just her fellow music and movie stars and not just at the end of her very successful career. She was that way her entire life. Dolly had what I consider to be the two keys to success: she was self-aware and was authentic. She was not born into wealth, her education stopped after finishing high school, maybe she was lucky, but she seemed to work hard, built wonderful relationships with people, and she clearly was able to recognize opportunities in the entertainment industry.
But at the end of the day, Dolly Parton was a talented and genuine person – she knew who she was and never strayed from it. She was able to build trust and was as authentic as it gets. Her life is a reminder that knowing who you are, staying true to it, and treating people well may be among the most enduring foundations of success—in life and in business.
Bob Jones, CEO
Beware of AI Without Expertise
AI is becoming ubiquitous in animal health, from diagnostics and market analysis to due diligence and fundraising. But its value—and its risk—depend heavily on who is using it. Experts rarely accept the first AI-generated answer. They challenge assumptions, test conclusions and iterate. Without that expertise, a polished output can too easily be mistaken for a reliable answer.
A recent lawsuit involving an Oregon veterinary hospital and an alleged misdiagnosis by an AI diagnostic tool illustrates the issue. Whatever the eventual outcome of the case, it raises an important question: when AI contributes to a recommendation, who is responsible for validating it? That answer applies whether interpreting diagnostics or advising on strategy, the professional remains responsible for the recommendation.
At Brakke, we are applying that principle to a program helping animal health startups and growth companies prepare for fundraising. AI can organize diligence materials, build checklists, identify documentation gaps and manage much of the preparation process. That can significantly reduce the number of expensive consulting hours required. But it does not eliminate the need for expertise. It allows experienced advisors to spend their time where judgment creates the most value: positioning, priorities, investor expectations and identifying the questions management may not know to ask.
AI may reduce the cost of expertise; however, it should not reduce the standards of expertise.
Alexis Nahama, Senior Consultant
